Annexin A2 regulates a disintegrin and metalloproteinase 17-mediated ectodomain shedding of pro-tumor necrosis factor-α in monocytes and colon epithelial cells

Inflammatory Bowel Diseases

Volumn 19, Issue 7, 2013, Pages 1365-1373

  Tsukamoto, Hironobu ^a   Tanida, Satoshi ^a   Ozeki, Keiji ^a   Ebi, Masahide ^a   Mizoshita, Tsutomu ^a   Shimura, Takaya ^a   Mori, Yoshinori ^a   Kataoka, Hiromi ^a   Kamiya, Takeshi ^a   Fukuda, Shinji ^b   Higashiyama, Shigeki ^b   Joh, Takashi ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

IBD treatment; Molecular target; Proinflammatory cytokine

Indexed keywords

ALKALINE PHOSPHATASE; AMPHIREGULIN; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; INTERLEUKIN 1BETA; LIPOCORTIN 2; PHORBOL 13 ACETATE 12 MYRISTATE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;

ARTICLE; COLON MUCOSA; CONTROLLED STUDY; CYTOKINE RELEASE; ENTERITIS; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME MECHANISM; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INTESTINE EPITHELIUM CELL; MONOCYTE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; WESTERN BLOTTING;

ADAM PROTEINS; ANNEXIN A2; BLOTTING, WESTERN; CARCINOGENS; CELL PROLIFERATION; CELLS, CULTURED; COLON; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOPRECIPITATION; INTERLEUKIN-1BETA; MONOCYTES; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TETRADECANOYLPHORBOL ACETATE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84879122737     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0b013e318281f43a     Document Type: Article

References (27)

1. Hanauer SB, Feagan BG, Lichtenstein GR, et al. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet. 2002;359:1541-1549.
2. Rutgeerts P, Sandborn WJ, Feagan BG, et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2005;353:2462-2476.
3. Hanauer SB, Sandborn WJ, Rutgeerts P, et al. Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial. Gastroenterology. 2006;130:323-333.
4. Billioud V, Sandborn WJ, Peyrin-Biroulet L. Loss of response and need for adalimumab dose intensification in Crohn's disease: a systematic review. Am J Gastroenterol. 2011;106:674-684.
5. Moss ML, Jin SL, Milla ME, et al. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature. 1997;385:733-736.
6. Black RA, Rauch CT, Kozlosky CJ, et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature. 1997;385:729-733.
7. Asakura M, Kitakaze M, Takashima S, et al. Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy. Nat Med. 2002;8:35-40.
8. Tanida S, Joh T, Itoh K, et al. The mechanism of cleavage of EGFR ligands induced by inflammatory cytokines in gastric cancer cells. Gastroenterology. 2004;127:559-569.
9. Nakayama H, Fukuda S, Inoue H, et al. Cell surface annexins regulate ADAM-mediated ectodomain shedding of proamphiregulin. Mol Biol Cell. 2012;23:1964-1975.
10. Tokumaru S, Higashiyama S, Endo T, et al. Ectodomain shedding of epidermal growth factor receptor ligands is required for keratinocyte migration in cutaneous wound healing. J Cell Biol. 2000;151:209-220.
11. Rosendahl MS, Ko SC, Long DL, et al. Identification and characterization of a pro-tumor necrosis factor-alpha-processing enzyme from the ADAM family of zinc metalloproteases. J Biol Chem. 1997;272:24588-24593.
12. McClane SJ, Rombeau JL. Cytokines and inflammatory bowel disease: a review. JPEN J Parenter Enteral Nutr. 1999;23:S20-S24.
13. Jung HC, Eckmann L, Yang SK, et al. A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J Clin Invest. 1995;95:55-65.
14. Kirkegaard T, Pedersen G, Saermark T, et al. Tumour necrosis factoralpha converting enzyme (TACE) activity in human colonic epithelial cells. Clin Exp Immunol. 2004;135:146-153.
15. Cesaro A, Abakar-Mahamat A, Brest P, et al. Differential expression and regulation of ADAM17 and TIMP3 in acute inflamed intestinal epithelia. Am J Physiol Gastrointest Liver Physiol. 2009;296:G1332-G1343.
16. Brynskov J, Foegh P, Pedersen G, et al. Tumour necrosis factor alpha converting enzyme (TACE) activity in the colonic mucosa of patients with inflammatory bowel disease. Gut. 2002;51:37-43.
17. Chalaris A, Adam N, Sina C, et al. Critical role of the disintegrin metalloprotease ADAM17 for intestinal inflammation and regeneration in mice. J Exp Med. 2010;207:1617-1624.
18. Gooz M. ADAM-17: the enzyme that does it all. Crit Rev Biochem Mol Biol. 2010;45:146-169.
19. Rescher U, Ruhe D, Ludwig C, et al. Annexin 2 is a phosphatidylinositol (4, 5)-bisphosphate binding protein recruited to actin assembly sites at cellular membranes. J Cell Sci. 2004;117:3473-3480.
20. Kim J, Hajjar KA. Annexin II: a plasminogen-plasminogen activator co-receptor. Fron Biosci. 2002;7:d341-d348.
21. Burkart A, Samii B, Corvera S, et al. Regulation of the SHP-2 tyrosine phosphatase by a novel cholesterol-and cell confluence-dependent mechanism. J Biol Chem. 2003;278:18360-18367.
22. Hansen MD, Ehrlich JS, Nelson WJ. Molecular mechanism for orienting membrane and actin dynamics to nascent cell-cell contacts in epithelial cells. J Biol Chem. 2002;277:45371-45376.
23. Kirshner J, Schumann D, Shively JE. CEACAM1, a cell-cell adhesion molecule, directly associates with annexin II in a three-dimensional model of mammary morphogenesis. J Biol Chem. 2003;278:50338-50345.
24. Babiychuk EB, Draeger A. Annexins in cell membrane dynamics. Ca (2+) - regulated association of lipid microdomains. J Cell Biol. 2000;150:1113-1124.
25. Draeger A, Monastyrskaya K, Burkhard FC, et al. Membrane segregation and downregulation of raft markers during sarcolemmal differentiation in skeletal muscle cells. Dev Biol. 2003;262:324-334.
26. Rescher U, Gerke V. Annexins-unique membrane binding proteins with diverse functions. J Cell Sci. 2004;117:2631-2639.
27. Frohlich M, Motte P, Galvin K, et al. Enhanced expression of the protein kinase substrate p36 in human hepatocellular carcinoma. Mol Cell Biol. 1990;10:3216-3223.